LIFECORE BIOMEDICAL, INC. \DE\ financial data

Symbol
LFCR on Nasdaq
Location
Chaska, MN
Fiscal year end
25 May
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 265% % 35%
Quick Ratio 111% % 6.3%
Debt-to-equity 12360% % 310%
Return On Assets -13% % -610%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37,466,352 shares 21%
Common Stock, Shares, Outstanding 37,466,352 shares 21%
Entity Public Float $201,592,285 USD 31%
Common Stock, Value, Issued $37,000 USD 19%
Weighted Average Number of Shares Outstanding, Basic 37,402,912 shares 21%
Weighted Average Number of Shares Outstanding, Diluted 37,402,912 shares 21%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $8,035,000 USD -6.7%
Operating Income (Loss) $8,728,000 USD 26%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $32,077,000 USD -655%
Income Tax Expense (Benefit) $401,000 USD 473%
Net Income (Loss) Attributable to Parent $32,478,000 USD -597%
Earnings Per Share, Basic -1 USD/shares -590%
Earnings Per Share, Diluted -1 USD/shares -787%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,856,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $30,303,000 USD
Inventory, Net $33,801,000 USD -19%
Assets, Current $83,928,000 USD 13%
Property, Plant and Equipment, Net $128,575,000 USD -14%
Operating Lease, Right-of-Use Asset $2,233,000 USD -11%
Intangible Assets, Net (Excluding Goodwill) $4,200,000 USD 0%
Goodwill $13,881,000 USD 0%
Other Assets, Noncurrent $4,620,000 USD 35%
Assets $235,204,000 USD -4.7%
Accounts Payable, Current $10,115,000 USD -44%
Employee-related Liabilities, Current $4,157,000 USD -25%
Accrued Liabilities, Current $19,843,000 USD
Contract with Customer, Liability, Current $7,214,000 USD
Liabilities, Current $29,958,000 USD -26%
Contract with Customer, Liability, Noncurrent $1,168,000 USD -76%
Deferred Income Tax Liabilities, Net $552,000 USD 33%
Operating Lease, Liability, Noncurrent $1,214,000 USD
Other Liabilities, Noncurrent $7,965,000 USD 56%
Liabilities $198,418,000 USD -4.3%
Retained Earnings (Accumulated Deficit) $218,095,000 USD -19%
Stockholders' Equity Attributable to Parent $10,537,000 USD -168%
Liabilities and Equity $235,204,000 USD -4.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,762,000 USD
Net Cash Provided by (Used in) Financing Activities $1,388,000 USD -227%
Net Cash Provided by (Used in) Investing Activities $1,737,000 USD 49%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 37,466,352 shares 21%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,363,000 USD 54%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18,856,000 USD 242%
Interest Paid, Excluding Capitalized Interest, Operating Activities $265,000 USD -58%
Deferred Tax Assets, Valuation Allowance $54,714,000 USD 18%
Deferred Tax Assets, Gross $73,471,000 USD 10%
Operating Lease, Liability $1,582,000 USD
Depreciation $1,981,000 USD -0.6%
Payments to Acquire Property, Plant, and Equipment $1,737,000 USD -49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,013,000 USD 82%
Lessee, Operating Lease, Liability, to be Paid $1,718,000 USD
Property, Plant and Equipment, Gross $188,197,000 USD -6.4%
Operating Lease, Liability, Current $368,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $414,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $410,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $136,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $144,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $40,677,000 USD -0.32%
Preferred Stock, Shares Issued 44,068 shares 7.5%
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $1,323,000 USD 4.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $148,000 USD
Operating Lease, Payments $102,000 USD 0.99%
Additional Paid in Capital $207,521,000 USD 16%
Preferred Stock, Shares Outstanding 44,068 shares 7.5%
Depreciation, Depletion and Amortization $1,981,000 USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance $18,757,000 USD -9.1%
Share-based Payment Arrangement, Expense $8,882,000 USD 84%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%